The javascript used on this site for creative design effects is not supported by your browser. Please note that this will not affect access to the content on this web site.
Skip Navigation
U.S. Department of Health and Human Services
  • YouTube
  • HRSA eNews
  • Print this
  • Email this

Stem Cell Therapeutic Outcomes Database Contract Summary

The Stem Cell Therapeutic Outcomes Database (SCTOD) is one of four components of the C.W. Bill Young Cell Transplantation Program (Program). According to the SCTOD contract, this contractor will:

  • Provide an electronic outcomes database of scientific information about allogeneic bone marrow and umbilical cord blood transplantation to be used by researchers and health care professionals.
  • Collect and analyze information about:
    • Diagnoses for which transplant may be a treatment option.
    • Transplant preparation and procedures.
    • Patient outcomes.
    • Patients' quality of life.
    • New uses for cells found in bone marrow, peripheral blood, and umbilical cord blood.
  • Work with transplant centers to ease the reporting of data.
  • Report information about:
    • The need for donors and cord blood units to policymakers, based on data from the Program.
    • Patient outcomes for each transplant center annually to the public.
    • Transplant research to the public, researchers, and health care professionals.
  • Store blood samples from donors and patients that will be used for transplant research.
  • Work closely with experts from all areas of bone marrow and cord blood transplantation.

To learn about the organization holding the SCTOD contract, see Center for International Blood and Marrow Transplant Research, a Program Contractor.

Program Contractor

Learn about the organization holding this contract.

Authorized to Help More Patients

Learn how the Program helps more patients have a successful bone marrow or umbilical cord blood transplant. The Program is authorized by the Stem Cell Therapeutic and Research Act of 2005, Public Law 109-129 and the Stem Cell Therapeutic and Research Reauthorization Act of 2010, Public Law 111-264.

Bone Marrow and Cord Blood Donation and Transplantation

A bone marrow or cord blood transplant (also called a BMT) replaces a patient's diseased cells with healthy blood-forming cells so that the patient can live a longer, healthier life. The blood-forming cells (stem cells) used for transplant can come from the patient (autologous) or from a relative or unrelated donor (allogeneic). Learn about:

The cells used for transplants HRSA Exit Disclaimer

Data about Bone Marrow and Cord Blood Transplantation

The SCTOD stores data about marrow and cord blood transplants and provides information for research to improve patient outcomes.

  • View statistics about transplants performed at transplant centers in the United States.